[1] Spiro RH. Salivary neoplasms: overview of a 35-years experiences with 2807 patients[J]. Head Neck Surg, 1986, 8(3): 177-180.
[2] Huang M, Ma D, Sun K, et al. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands[J]. Int J Oral Maxillofac Surg, 1997, 26(6):435-439.
[3] Bobbio A, Copelli C, Ampollini L, et al. Lung metastasis resection of adenoid cystic carcinoma of salivary glands[J]. Eur J Cardiothorac Surg, 2008, 33(5):790-793.
[4] Mourelatou EA, Libster D, Nir I. Type and location of interaction between hyperbranched polymers and liposomes. Relevance to design of a potentially advanced drug delivery nanosystem (aDDnS)[J]. J Phys Chem B, 2011, 115(13):3400-3408.
[5] Sharma HS. Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery[J]. J Neural Transm, 2011, 118(1):3-6.
[6] Haag R, Kratz F. Polymer therapeutics: concepts and applications[J]. Angew Chem Int Ed Engl, 2006, 45(8):1198-1215.
[7] Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase1 as an intracellular target of the anticancer drug camptothecin[J]. Cancer Res, 1988, 48(7):1722-1726.
[8] M Hu, M Chen, G Li, et al. Biodegradable hyperbranched polyglycerol with ester linkages for drug delivery[J]. Biomacromolecules, 2012, 13(11):3552-3561.
[9] Liu Y, Lou C, Yang H. Silica nanoparticales as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances[J]. Curr Cancer Drug Targets, 2011, 11(2):156-163.
[10] Xu Q, Liu Y, Su S. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymers nanoparticles[J]. Biomaterials, 2012, 33(5):1627-1639.
[11] Piskin E. Biodegradable polymers as biomaterials[J]. J Biomater Sci Polym Ed, 1995, 6(9):775-795.
[12] Saha RN, Vasanthakumar S, Bende G, et al. Nanoparticulate drug delivery systems for cancer chemotherapy[J]. Mol Membr Biol, 2010, 27(7):215-231.
[13] Jiang M, Wang T, Xu Q, et al. Novel amphiphilic hyperbranched poly (amine-ester) copolymers nanoparticles as protein drug delivery[J]. Mini Rev Med Chem, 2009, 9(11):1342-1356.
[14] Taylor DK, Jayes FL, House AJ. Temperature-responsive biocompatible copolymers incorporation hyperbanched polyglycerols for adjustable functionality[J]. J Funct Biomater, 2011, 2(3):173-194.
[15] M Chen, M Hu, D Wang, et al. Multi-functional hyperbranched glycoconjugated polymers based on natural aminoglycosides[J]. Bioconjugate Chem, 2012, 23(6):1189-1199.
[16] Testa B. Prodrug research: futile or fertile[J] Biochem Pharmacol, 2004, 68(11):2097-2106. |